查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1611220

眼科藥物輸送系統市場規模、佔有率、趨勢分析報告：按技術、輸送途徑、生產技術、材料、地區和細分市場預測，2025-2030年

Ophthalmic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Technology (Eye Drops, Contact Lenses), By Delivery Route, By Production Technology, By Material, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10個工作天內

價格

眼科給藥系統市場成長與趨勢

Grand View Research, Inc.最新報告顯示，到2030年，全球眼科給藥系統市場規模預計將達到233.6億美元。預計2025年至2030年該市場將以6.6%的複合年成長率擴張。眼科疾病盛行率的增加、需要細緻術後護理的眼科手術數量的增加以及為兒童和老年人提供受控劑型的需求不斷增加等因素預計將推動市場的成長。此外，對技術進步的持續關注進一步支持了市場的顯著成長。例如，製造商對奈米技術的直接關注實現了無錯誤的藥物輸送並提高了藥物滲透到目標部位的水平。

在 COVID-19 大流行的上半年，眼科給藥系統的銷售量直線下降。由於各國的封鎖和各種政府法規，前往醫院和診所就診的患者數量減少。此外，供應鏈中斷也導致這些產品短缺，這對整體市場產生了負面影響。然而，由於政府透過大規模疫苗接種計劃和對研發活動的大量投資來遏制病毒的傳播並限制病毒造成的負面影響，預計市場將在預測期內復甦。

眼科給藥系統市場報告亮點

  • 眼藥水細分市場收益佔有率最高，並在 2024 年佔據市場主導地位。由於眼藥水是最方便且對患者友好的技術，因此在大多數眼科手術中通常建議將其作為一線治療方法，以限制疾病的影響。
  • 眼內細分市場由於其無菌、低過敏性、易於配製眼藥水以及提高不溶於淚液的藥物的眼內生物有效性等優點，在2024年佔據最高的銷售佔有率。
  • 按生產技術分類，由於越來越多採用配方技術生產的局部眼藥水，配方細分市場在 2024 年佔據了最高的市場佔有率。
  • 按材料分類，水凝膠細分市場在 2024 年佔據最高市場佔有率。
  • 由於眼部病患病率不斷上升、熟練專業人員的存在以及政府機構為防止失明採取的各種舉措，北美在 2024 年佔據了最高的市場佔有率。
  • COVID-19 大流行對市場產生了負面影響。醫療保健優先事項的變化、社交距離和全球封鎖減少了患者到醫院和診所就診的次數。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章眼科給藥系統市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/補充市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 眼科給藥系統市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章眼科給藥系統市場：依技術估計與趨勢分析

  • 細分儀表板
  • 全球眼科給藥系統市場技術波動分析
  • 2018-2030年全球眼科給藥系統市場規模及趨勢分析（依技術）
  • 眼藥水
  • 隱形眼鏡
  • 淚點塞
  • 植入外層植入物
  • 玻璃體內植入
  • 噴射顆粒系統
  • 離子電滲
  • 微機電
  • 奈米載體
  • 奈米顆粒
  • 微型針
  • 水凝膠
  • 其他

第5章眼科給藥系統市場：依給藥途徑的估計與趨勢分析

  • 細分儀表板
  • 全球眼科給藥系統市場給藥途徑波動分析
  • 2018-2030年全球眼科給藥系統市場規模及趨勢分析（依給藥途徑）
  • 靜電紡絲
  • 3D列印
  • 擠出成型
  • 組合
  • 微圖形化
  • 壓縮成型
  • 其他

第6章眼科給藥系統市場：依生產技術估計與趨勢分析

  • 細分儀表板
  • 全球眼科給藥系統市場生產技術波動分析
  • 2018-2030年全球眼科給藥系統市場規模及趨勢分析（依生產技術）
  • 脂質體
  • 膠原蛋白
  • PLA-PEG
  • PDO/PVA
  • 水凝膠
  • TMC
  • 聚原酸酯
  • PLGA
  • 脂肪酸
  • 其他

第7章眼科給藥系統市場：依材料估計與趨勢分析

  • 細分儀表板
  • 全球眼科給藥系統市場材料波動分析
  • 2018-2030年全球眼科給藥系統市場規模及趨勢分析（依資料）
  • 脂質體
  • 膠原蛋白
  • PLA-PEG
  • PDO/PVA
  • 水凝膠
  • TMC
  • 聚原酸酯
  • PLGA
  • 脂肪酸
  • 其他

第8章眼科給藥系統市場：區域、估計和趨勢分析

  • 2023 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場分析
  • 主要身份驗證提供者/方案所有者列表
  • 公司簡介/上市公司
    • Ocular Therapeutix Inc.
    • Allergan plc.
    • Santen Pharmaceutical Co. Ltd.
    • Envisia Therapeutics
    • pSivida
    • Clearside Biomedical
    • Oculis Pharma
    • Valeant Pharmaceuticals
    • AptarGroup, Inc.
    • 公司簡介
Product Code: GVR-4-68039-917-7

Ophthalmic Drug Delivery Systems Market Growth & Trends:

The global ophthalmic drug delivery systems market size is projected to reach USD 23.36 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.6% from 2025 to 2030. Factors such as growing prevalence of ophthalmic diseases, rise in number of ophthalmic procedures that require attentive post procedural care and increase in need to deliver controlled dosage forms for pediatric and geriatric population are anticipated to propel the growth of the market. In addition, immense focus on technological advancements is further helping the market to grow at a significant rate. For instance, manufacturers' instant focus on nanotechnology has helped to deliver error-free drug delivery and increase the penetration level of the drug at the target site.

The market observed a sudden fall in sales of ophthalmic drug delivery systems during the first half of the COVID-19 pandemic. The lockdowns across different countries and various restrictions led down by the government led to fall in number of patient's visits to the hospitals and clinics. Moreover, the disruption in supply chains also led to a shortage of these products which indicates an overall negative impact on the market. However, with the government's initiatives to curb the spread of the virus and limit the negative consequences it possesses via mass vaccination programs and heavy investment in R&D activities, the market is expected to recover over the forecast period.

Ophthalmic Drug Delivery Systems Market Report Highlights:

  • The eye drops segment dominated the market with highest revenue share in 2024 as eye drops are often recommended as the first line of treatment in most of the ophthalmic procedures to control the effect of the disease as it is the most convenient and patient compliant technology.
  • The intraocular segment held the highest revenue share in 2024 owing to the advantages it offers such as sterilization, less irritation, ease of eye drops formulation and enhancement in ocular bioavailability of drugs that are insoluble in tear fluid.
  • On the basis of production technology, the formulation segment accounted for highest market share in 2024 owing to increase in adoption of topical eye drops which is produced through the formulation technology.
  • Based on material, the hydrogels segment held the highest market share in 2024 owing to the advantages it offers over other materials.
  • North America accounted for highest market share in 2024 due to increasing incidence of ophthalmic disorders, presence of skilled professionals and various initiatives undertaken by the government agencies to prevent blindness in the region.
  • The COVID-19 pandemic has a negative impact on the market. Due to change in healthcare priorities, social distancing, worldwide lockdowns led to reduced patient visits to the hospitals and clinics.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Technology Segment
    • 1.2.2. Delivery Route Segment
    • 1.2.3. Production Technology Segment
    • 1.2.4. Material Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Segment Snapshot
  • 2.4. Competitive Insights Landscape

Chapter 3. Ophthalmic Drug Delivery Systems Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Ophthalmic Drug Delivery Systems Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Ophthalmic Drug Delivery Systems Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Ophthalmic Drug Delivery Systems Market Technology Movement Analysis
  • 4.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Technology, 2018 - 2030 (USD Billion)
  • 4.4. Eye Drops
    • 4.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.5. Contact Lenses
    • 4.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.6. Punctal Plugs
    • 4.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.7. Episcleral Implants
      • 4.7.1.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.8. Intraviteal Implants
    • 4.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.9. Injectable Particulate Systems
    • 4.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.10. Iontophoresis
    • 4.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.11. Micro-Electromechanical
    • 4.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.12. Nano careers
    • 4.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.13. Nano microparticles
    • 4.13.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.14. Microneedles
    • 4.14.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.15. Hydrogels
    • 4.15.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 4.16. Others
    • 4.16.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. Ophthalmic Drug Delivery Systems Market: Delivery Route Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Ophthalmic Drug Delivery Systems Market Delivery Route Movement Analysis
  • 5.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Delivery Route, 2018 - 2030 (USD Billion)
  • 5.4. Electrospinning
    • 5.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.5. 3D Printing
    • 5.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.6. Extrusion
    • 5.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.7. Formulation
    • 5.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.8. Micropatterning
    • 5.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.9. Compression molding
    • 5.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 6. Ophthalmic Drug Delivery Systems Market: Production Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Ophthalmic Drug Delivery Systems Market Production Technology Movement Analysis
  • 6.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Production Technology, 2018 - 2030 (USD Billion)
  • 6.4. Liposomes
    • 6.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.5. Collagen
    • 6.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.6. PLA-PEG
    • 6.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.7. PDO/PVA
    • 6.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.8. Hydrogels
    • 6.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.9. TMC
    • 6.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.10. Polyorthoesters
    • 6.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.11. PLGA
    • 6.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.12. Fatty acids
    • 6.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 6.13. Others
    • 6.13.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 7. Ophthalmic Drug Delivery Systems Market: Material Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Ophthalmic Drug Delivery Systems Market Material Movement Analysis
  • 7.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Material, 2018 - 2030 (USD Billion)
  • 7.4. Liposomes
    • 7.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.5. Collagen
    • 7.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.6. PLA-PEG
    • 7.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.7. PDO/PVA
    • 7.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.8. Hydrogels
    • 7.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.9. TMC
    • 7.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.10. Polyorthoesters
    • 7.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.11. PLGA
    • 7.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.12. Fatty acids
    • 7.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
  • 7.13. Others
    • 7.13.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 8. Ophthalmic Drug Delivery Systems Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Competitive scenario
      • 8.4.1.3. Regulatory framework
      • 8.4.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Competitive scenario
      • 8.5.1.3. Regulatory framework
      • 8.5.1.4. UK market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. France market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.5.6. Denmark
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Denmark market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.5.8. Norway
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Competitive scenario
      • 8.5.8.3. Regulatory framework
      • 8.5.8.4. Norway market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Competitive scenario
      • 8.6.1.3. Regulatory framework
      • 8.6.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. China market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. India market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Competitive scenario
      • 8.6.4.3. Regulatory framework
      • 8.6.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Competitive scenario
      • 8.6.5.3. Regulatory framework
      • 8.6.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Competitive scenario
      • 8.6.6.3. Regulatory framework
      • 8.6.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Competitive scenario
      • 8.7.1.3. Regulatory framework
      • 8.7.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Competitive scenario
      • 8.8.1.3. Regulatory framework
      • 8.8.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive scenario
      • 8.8.2.3. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive scenario
      • 8.8.3.3. Regulatory framework
      • 8.8.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Billion)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive scenario
      • 8.8.4.3. Regulatory framework
      • 8.8.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. List of Key Certification Providers/Scheme Owners
  • 9.5. Company Profiles/Listing
    • 9.5.1. Ocular Therapeutix Inc.
      • 9.5.1.1. Company overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Technology benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Allergan plc.
      • 9.5.2.1. Company overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Technology benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Santen Pharmaceutical Co. Ltd.
      • 9.5.3.1. Company overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Technology benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Envisia Therapeutics
      • 9.5.4.1. Company overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Technology benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. pSivida
      • 9.5.5.1. Company overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Technology benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Clearside Biomedical
      • 9.5.6.1. Company overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Technology benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Oculis Pharma
      • 9.5.7.1. Company overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Technology benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Valeant Pharmaceuticals
      • 9.5.8.1. Company overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Technology benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. AptarGroup, Inc.
    • 9.5.9. Company overview
      • 9.5.9.1. Financial performance
      • 9.5.9.2. Technology benchmarking
      • 9.5.9.3. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global ophthalmic drug delivery systems market, by region, 2018 - 2030 (USD Billion)
  • Table 3 Global ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 4 Global ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 5 Global ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 6 Global ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 7 North America ophthalmic drug delivery systems market, by country, 2018 - 2030 (USD Billion)
  • Table 8 North America ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 9 North America ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 10 North America ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 11 North America ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 12 U.S. ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 13 U.S. ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 14 U.S. ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 15 U.S. ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 16 Canada ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 17 Canada ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 18 Canada ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 19 Canada ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 20 Mexico ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 21 Mexico ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 22 Mexico ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 23 Mexico ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 24 Europe ophthalmic drug delivery systems market, by country, 2018 - 2030 (USD Billion)
  • Table 25 Europe ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 26 Europe ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 27 Europe ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 28 Europe ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 29 UK ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 30 UK ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 31 UK ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 32 UK ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 33 Germany ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 34 Germany ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 35 Germany ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 36 Germany ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 37 France ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 38 France ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 39 France ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 40 France ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 41 Italy ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 42 Italy ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 43 Italy ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 44 Italy ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 45 Spain ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 46 Spain ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 47 Spain ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 48 Spain ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 49 Denmark ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 50 Denmark ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 51 Denmark ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 52 Denmark ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 53 Sweden ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 54 Sweden ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 55 Sweden ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 56 Sweden ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 57 Norway ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 58 Norway ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 59 Norway ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 60 Norway ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 61 Asia Pacific ophthalmic drug delivery systems market, by country, 2018 - 2030 (USD Billion)
  • Table 62 Asia Pacific ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 63 Asia Pacific ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 64 Asia Pacific ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 65 Asia Pacific ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 66 Japan ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 67 Japan ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 68 Japan ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 69 Japan ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 70 China ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 71 China ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 72 China ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 73 China ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 74 India ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 75 India ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 76 India ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 77 India ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 78 Australia ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 79 Australia ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 80 Australia ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 81 Australia ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 82 South Korea ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 83 South Korea ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 84 South Korea ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 85 South Korea ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 86 Thailand ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 87 Thailand ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 88 Thailand ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 89 Thailand ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 90 Latin America ophthalmic drug delivery systems market, by country, 2018 - 2030 (USD Billion)
  • Table 91 Latin America ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 92 Latin America ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 93 Latin America ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 94 Latin America ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 95 Brazil ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 96 Brazil ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 97 Brazil ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 98 Brazil ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 99 Argentina ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 100 Argentina ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 101 Argentina ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 102 Argentina ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 103 MEA ophthalmic drug delivery systems market, by country, 2018 - 2030 (USD Billion)
  • Table 104 MEA ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 105 MEA ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 106 MEA ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 107 MEA ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 108 South Africa ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 109 South Africa ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 110 South Africa ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 111 South Africa ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 112 Saudi Arabia ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 113 Saudi Arabia ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 114 Saudi Arabia ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 115 Saudi Arabia ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 116 UAE ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 117 UAE ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 118 UAE ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 119 UAE ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
  • Table 120 Kuwait ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
  • Table 121 Kuwait ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
  • Table 122 Kuwait ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
  • Table 123 Kuwait ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Ophthalmic drug delivery systems market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Ophthalmic drug delivery systems market: Technology outlook key takeaways
  • Fig. 20 Ophthalmic drug delivery systems market: Technology movement analysis
  • Fig. 21 Eye drops market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Contact lenses market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Punctal plugs market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Episcleral implants market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 25 Intravitreal implants market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 26 Injectable particulate systems market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Iontophoresis market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Micro-Electromechanical market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Nano careers market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Nano microparticles market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 Microneedles market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 32 Hydrogels market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Ophthalmic drug delivery systems market: Delivery route outlook key takeaways
  • Fig. 35 Ophthalmic drug delivery systems market: Delivery route movement analysis
  • Fig. 36 Intraocular market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 37 Intravitreal market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 38 Intracameral market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 39 Ophthalmic drug delivery systems market: Production technology outlook key takeaways
  • Fig. 40 Ophthalmic drug delivery systems market: Production technology movement analysis
  • Fig. 41 Electrospinning market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 42 3D printing market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 43 Formulation market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 44 Micro patterning market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 45 Compression molding market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 46 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 47 Ophthalmic drug delivery systems market: Material outlook key takeaways
  • Fig. 48 Ophthalmic drug delivery systems market: Material movement analysis
  • Fig. 49 Liposomes market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 50 Collagen market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 51 PLA-PEG market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 52 PDO/PVA market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 53 Hydrogels market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 54 TMC market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 55 Polyorthoesters market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 56 PLGA market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 57 Polycaprolactone market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 58 Fatty acids market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 59 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 60 Regional marketplace outlook, 2024 & 2030 (USD Billion)
  • Fig. 61 Regional marketplace: Key takeaways
  • Fig. 62 North America ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Key country dynamics
  • Fig. 64 U.S. ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 Key country dynamics
  • Fig. 66 Canada ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 67 Key country dynamics
  • Fig. 68 Mexico ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 69 Europe ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 70 Key country dynamics
  • Fig. 71 UK ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 72 Key country dynamics
  • Fig. 73 Germany ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 74 Key country dynamics
  • Fig. 75 France ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 76 Key country dynamics
  • Fig. 77 Spain ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 78 Key country dynamics
  • Fig. 79 Italy ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 80 Key country dynamics
  • Fig. 81 Denmark ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 82 Key country dynamics
  • Fig. 83 Sweden ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 84 Key country dynamics
  • Fig. 85 Norway ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 86 Asia Pacific ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 87 Key country dynamics
  • Fig. 88 Japan ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 89 Key country dynamics
  • Fig. 90 China ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 91 Key country dynamics
  • Fig. 92 India ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 93 Key country dynamics
  • Fig. 94 Australia ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 95 Key country dynamics
  • Fig. 96 South Korea ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 97 Key country dynamics
  • Fig. 98 Thailand ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 99 Key country dynamics
  • Fig. 100 Market participant categorization
  • Fig. 101 Ophthalmic drug delivery systems market position analysis, 2023
  • Fig. 102 Strategic framework